We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Indian biotech firm Saket Biotechnologies has announced its readiness to license
out its new drug delivery systems (NDDS) technology, which enables proteins
and peptides to be taken orally.